Sponsor Dossier

Aspen Pharmacare

Sponsor Dossier for Aspen Pharmacare. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.

About

Aspen Pharmacare is an Australian Private Company with ABN 51 096 236 985, registered in New South Wales. The company is active and has been registered for goods and services tax purposes since 2001.

Portfolio

Aspen Pharmacare holds 170 brands on the Australian Register of Therapeutic Goods, of which 121 are indexable. The portfolio includes 117 brands with Product Information on file, 55 brands with at least one PBS-listed item, 12 brands with PBAC outcomes on record, and 2 brands with AusPARs on record.

Therapeutic focus

Aspen Pharmacare's portfolio spans 21 therapeutic areas, with the following distribution: — Infectious Disease: 33 brands — Neurology: 22 brands — Oncology: 20 brands — Cardiology: 15 brands — Endocrinology: 11 brands — Pain Management: 11 brands — Pain & Anaesthesia: 9 brands — Dermatology: 9 brands — Ophthalmology: 8 brands — Gastroenterology: 7 brands — Haematology: 5 brands — Complementary Medicine: 5 brands — Immunology: 3 brands — Respiratory: 3 brands — Women's Health: 2 brands — Other: 2 brands — Urology: 1 brand — Uncategorised: 1 brand — Reproductive Health: 1 brand — Psychiatry: 1 brand — Renal: 1 brand

PBS footprint

Aspen Pharmacare has 55 brands with at least one PBS-listed item, with the portfolio's latest PBS schedule date being 2026-05-01.

Regulatory activity

Aspen Pharmacare's most recent PBAC outcome was recorded on 2024-07-01, with 12 brands holding PBAC outcomes on record. The most recent AusPAR was recorded on 2024-07-16, with 2 brands holding AusPARs on record.

ABR record